Clinical Observation Of The Treatment Of Chronic Obstructive Pulmonary Disease With Stable Lung And Kidney Qi Deficiency By Bufeifeishen Method

Purpose: Through the clinical observation of "replenishing lung and kidney" on the stable "lung and kidney qi deficiency" chronic obstructive pulmonary disease in patients with clinical efficacy.To verify the feasibility of replenishing lung and kidney method.For the treatment of chronic obstructive pulmonary disease in Chinese medicine to provide a new and effective method.Material and method: The clinical subjects were in December 2014-June 2016 in Liaoning University of Traditional Chinese Medicine affiliated hospital lung disease outpatient treatment of chronic obstructive pulmonary disease in patients with stable lung and kidney qi deficiency type.Using a randomized grouping method,65 patients who met the inclusion criteria were divided into treatment group and control group,treatment group(n = 32)and control group(n = 33).The control group was treated with conventional western medicine: Salmeterol inhalation powder(trade name: sulindi),specifications:50ug / 500 ug,each time a suction,2 times a day;Treatment group in the conventional treatment of Western medicine on the basis of the addition to the benefit of the lung and kidney for the law of the gold and kidney cream.Treatment for three months.The number of acute exacerbations were measured before and after treatment.And the results were analyzed by SPSS17.0 statistical software package.Results: 1.There was no significant difference in sex,age,course of disease,grade of lung function,symptom score,quality of life questionnaire and acute exacerbation of treatment group and control group(P> 0.05).2.Number of acute exacerbations: The number of acute exacerbations in the treatment group was decreased(P <0.05).There was no decrease in the number of acute exacerbations after follow-up(P> 0.05).There were significant differences between the two groups after follow-up(P <0.05).3.Clinical symptoms: After treatment,the six symptom scores of the wheezing,shortness of breath,cough,expectoration,susceptible to cold,waist and knee were decreased(P<0.05).After treatment,the five symptom scores of wheezing,shortness of breath,cough,expectoration and susceptibility to cold were decreased(P <0.05).There were significant differences between the two groups in the four indexes of cough,shortness of breath,easy to cold,Yaoxisuan and so on(P <0.05).The treatment group was better than the control group.4.TCM syndrome points: the treatment group after treatment of TCM syndrome total score decreased(P<0.05).The total score of TCM syndromes decreased after treatment(P <0.05).There was significant difference between the two groups after treatment(P<0.05),the treatment group was better than the control group.5.Pulmonary function: FEV1% and FEV1 / FVC %were improved in the treatment group(P <0.05).The FEV1% and FEV1 / FVC% were improved in the control group(P<0.05).There was no significant difference between the two groups after treatment(P> 0.05).6.Quality of life: the quality of life scores improved in the treatment group after treatment(P<0.05).The quality of life score of the control group was improved after treatment(P<0.05).There was significant difference between the two groups after treatment(P <0.05),the treatment group was better than the control group.Conclusion: Through the benefit of lung and kidney treatment of chronic obstructive pulmonary disease in patients with stable lung and kidney qi deficiency clinical observation o,significant effect.Indicating that the benefit of lung and kidney disease for the treatment of chronic obstructive pulmonary disease stable treatment.